Tern Plc announces Talking Medicines fundraise, raises £440,000 for expansion

Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things technology businesses, has announced that Talking Medicines Limited, a company in which Tern holds 23.8% of the equity, has undertaken a fundraising round, securing £440,000 in new investment via the issue of unsecured convertible loan notes from Tern and other existing Talking Medicines shareholders.  

Highlights

·    Talking Medicines has raised a total of £440,000 via the issue of unsecured convertible loan notes (the “2024 CLNs”) to Tern and other existing Talking Medicines shareholders

·    Tern has subscribed for £100,000 of the 2024 CLNs

·    The Talking Medicines Fundraise is intended to provide Talking Medicines with further funding to enable it to grow in line with its strategy, in particular by expanding its US activities

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Tern plc

More articles like this

Tern plc

How AI-human synergy is rewriting the rules of Pharma Marketing

AI is no longer a futuristic concept in Pharma Marketing—it’s a powerful force already reshaping strategy, precision, and personalisation at scale. But its real magic happens when it partners with human expertise, unlocking smarter, more responsive